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An unusual case of verrucous lupus
Stephanie Chapman MD, Jesse Veenstra MD, PhD, Henry Lim MD
Department of Dermatology, Henry Ford Health System

HISTORY

COURSE AND THERAPY

CLINICAL PHOTOS

• Chronic cutaneous lupus was recalcitrant to
plaquenil monotherapy, topical and intralesional
corticosteroids
• In coordination with rheumatology, we added
Cellcept 1500 mg BID to regimen of plaquenil 200
mg QD with improvement
• Tazorac 0.1% gel every other night to the rough
areas of the face with improvement
• At last visit, planned to start hydroquinone 2%
cream 1-2 times daily to the dark areas on the face
• Strict photoprotection with daily sunscreen use

• 56 year-old African American female with a 10-year
history of dark patches involving the forehead, malar
cheeks, nose, ears, upper back and extremities
• The dark patches were pruritic and accompanied by an
intermittent burning sensation
• The patches darkened over the years and became more
rough in texture
• Past medical history was significant for a 10-year history
of discoid lupus erythematosus (DLE) and systemic
lupus erythematosus (SLE) made at an outside facility
for which she was taking plaquenil, and a hospitalization
for myositis in 2010
• Family history was unknown

DISCUSSION

EXAMINATION AND LABS
• On the face, in a photo-distributed pattern, there were
hyperpigmented patches and plaques with verrucous like
texture
• Hyperpigmented macules of the bilateral conchal bowls,
helix and scaphoid fossa
• All proximal nail folds on the fingers exhibited a
variable level of edema and erythema
• The oral mucosa was uninvolved.
• ANA titer of 1:1280 (speckled pattern)
• Complement levels and activity, dsDNA, ENA, SSA/B,
cardiolipin studies, and urinalysis all normal

PATHOLOGY
• H&E punch biopsy from right medial canthus
• Few pigmented particles in the stratum corneum
• Markedly thickened basement membrane with
underlying dermal melanophages scattered throughout
the papillary dermis
• No evidence of active inflammation
• Perls’ stain negative for the presence of iron

Figure 1: Verrucous hyperpigmented
plaques upon presentation to Henry Ford
Dermatology

Figure 2: Improvement of
hyperpigmentation and rough texture
after 4 months of treatment

CLASSIFICATION

Types of cutaneous
lupus

Acute cutaneous
lupus (ACLE)

Subacute cutaneous
lupus (SCLE)

Chronic cutaneous
lupus (CCLE)

DLE, lupus
panniculitis, lupus
tumidus, chilblain
lupus
Risk for systemic diseaase
Figure 3: Classification of cutaneous lupus and relative risk of systemic disease1

• Lesions of DLE commonly involve the scalp, face, ears
• Coin-shaped, well-demarcated plaques that progress into
dyspigmented scars1
• First line treatments include topical corticosteroids,
topical calcineurin inhibitors, and systemic antimalarial
therapy in conjunction with photoprotection2
• About 10-20% of patients who present with discoid
lesions progress to meet criteria for (SLE), with the
majority of these patients progressing within 5 years
• Hypertrophic DLE, a rare variant occurring in 2% of
patients with DLE, is characterized by hyperkeratotic,
verrucous plaques predominately involving the extensor
3
surfaces of the upper extremities, trunk, and face
• Hypertrophic DLE is often more resistant to treatment
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